The Chosun Ilbo on MSN
KAIST unveils B-cell targeting AI cancer vaccine
The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...
The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...
FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...
TipRanks on MSN
Nanjing Leads Biolabs doses first subject in Phase I trial of autoimmune drug LBL-047
The latest update is out from Nanjing Leads Biolabs Co., Ltd. Class H ( ($HK:9887) ). Nanjing Leads Biolabs has begun dosing the first subject in ...
This work reveals metabolic pathways and molecular events mechanistically linked to B cell activation. Using an unbiased, comprehensive proteome profiling method and various functional validation ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. In many autoimmune pathologies, including Rheumatoid Arthritis (RA), only a small ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In this case series, four ...
However, details of the intervening steps, as researchers have learned in the past 65 years, are quite complex — certain cells carry the flu antigen to the immune system, specific immune cells respond ...
Survival outcomes of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified: Results from Latin American and United States cohorts. This is an ASCO Meeting Abstract from ...
Cancer antigen discovery has mostly focused on T cell antigens, while antigens driving B cell responses have been largely overlooked despite representing another important branch of adaptive immune ...
Please provide your email address to receive an email when new articles are posted on . Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 ...
Objectives B-cell depletion time after rituximab (RTX) treatment is prolonged in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) compared with other autoimmune diseases. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results